Sugi Predict

Sugi Predict / Compounds / SCHEMBL19120239

SCHEMBL19120239

SCHEMBL19120239

c1ccc(-c2nc(-n3c4ccccc4c4c5c6ccccc6sc5c5ccccc5c43)c3c(n2)sc2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.34
▸ HPGD P15428 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ PIK3CA P42336 1/20 0.32
▸ ACP1 P24666 2/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ NPC1 O15118 2/20 0.31
▸ GAA P10253 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ ADORA2A P29274 2/20 0.31
▸ ADORA1 P30542 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19120261 0.93 ADORA2A (0.31) ADORA2AADORA1
SCHEMBL20655805 0.92 KDM4E (0.33) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL20655927 0.92 KDM4E (0.33) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL19247177 0.90 KDM4E (0.33) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL20656111 0.89 KDM4E (0.34) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL19247581 0.88 KDM4E (0.33) KDM4EHPGDALDH1A1HSD17B10TSHR
SCHEMBL20655829 0.88 KDM4E (0.32) KDM4E
SCHEMBL20655756 0.87 KDM4E (0.33) KDM4E
SCHEMBL20656097 0.87 LIMK1 (0.31) —
SCHEMBL19247263 0.87 KDM4E (0.34) KDM4EHPGDALDH1A1HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10468606-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2019-11-05 — — US disclosed
US-20190019962-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2019-01-17 — — US disclosed
WO-2017119654-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC APPARATUS THEREFOR 덕산네오룩스 주식회사 2017-07-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190019962-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, OR10J3 KDM4E 997/4885HPGD 3248/4885ALDH1A1 739/4885
US-10468606-B2 Compound for organic electric element, organic electric element comprising the same, and electronic device thereof PIEZO1, OCIAD1, OR10J3 KDM4E 997/4885HPGD 3248/4885ALDH1A1 739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.